Edit This Favorite

In the latest Zika developments, Japan-based Takeda today announced the launch of a phase 1 trial of its Zika virus vaccine, and Chembio Diagnostics, based in New York City, said it has been awarded a contract from UNICEF for the purchase of its Zika point-of-care testing system.

OSAP Disclaimer | Please notify our webmaster of any problems with this website.OSAP thanks its Super Sponsors for their support in 2017. Sponsorship does not imply endorsement by OSAP of a company's products or services.